Skip Navigation LinksHome > July 2, 2002 - Volume 13 - Issue 9 > Neurokinin-1 receptors are decreased in major depressive dis...
Clinical Neuroscience and Neuropathology: Clinical Neuroscience

Neurokinin-1 receptors are decreased in major depressive disorder

Stockmeier, Craig A.CA; Shi, Xiaochun; Konick, Lisa1; Overholser, James C.2; Jurjus, George1; Meltzer, Herbert Y.1; Friedman, Lee3; Blier, Pierre4; Rajkowska, Grazyna

Collapse Box


Treatment with an antagonist at the neurokinin-1 (NK-1) receptor may alleviate depression, however the brain region(s) in which the NK-1 receptor antagonist exerts its therapeutic effect is unknown. [125I]BH-Substance P was used to measure NK-1 receptors postmortem in cytoarchitectonically defined areas of rostral orbitofrontal cortex (Brodmann's area 47) of subjects with major depressive disorder (n  = 12, six females) and psychiatrically normal subjects (n  = 11, five females). Six subjects with depression died by suicide. Subjects with depression showed decreased binding to NK-1 receptors across all cortical layers (p  = 0.024). The pathophysiology of depression, and the reported therapeutic benefit of NK-1 receptor antagonists, may thus involve NK-1 receptors in prefrontal cortex.

© 2002 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.